Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Alimentary Pharmacology & Therapeutics|June 21, 2021
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver diseaseYu-Jie Zhou, Feng Gao, Wen-Yue Liu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 2, 2017
NAFL screening score: A basic score identifying ultrasound-diagnosed non-alcoholic fatty liverYu-Jie Zhou, Yi-Fan Zhou, Ji-Na Zheng, et al.
Expert Review of Gastroenterology & Hepatology|January 18, 2017
Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort studyYu-Jie Zhou, Hai Zou, Ji-Na Zheng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2026
Liver-Pancreas Fat Deposition: Impact on Cardiometabolic Multimorbidity and Cardiac DysfunctionLi-You Lian, Tianyi Xia, Zhong-Wei Chen, et al.
BMJ Open Diabetes Research & Care|March 7, 2020
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levelsKenneth I Zheng, Wen-Yue Liu, Xiao-Yan Pan, et al.
United European Gastroenterology Journal|October 31, 2019
Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogramYu-Jie Zhou, Fang-Zhou Ye, Yang-Yang Li, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 6, 2018
MetS Risk Score: A Clear Scoring Model to Predict a 3-Year Risk for Metabolic SyndromeTian-Tian Zou, Yu-Jie Zhou, Xiao-Dong Zhou, et al.
Hepatology International|July 13, 2022
Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in maleXiao-Yan Pan, Wen-Yue Liu, Pei-Wu Zhu, et al.
Oncotargets and Therapy|December 8, 2015
High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinomaNan-Bo Liu, Jun-Hua Zhang, Yu-Fan Liu, et al.
Journal of Gastroenterology and Hepatology|April 5, 2020
Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver diseaseFeng Gao, Jiao-Feng Huang, Kenneth I Zheng, et al.
Pageof 11